| Factor Information | |
|---|---|
| Data ID | 2559 |
| Factor | VWF:Ag (U/dL) |
| Description | VWF:Ag=plasma von Willebrand factor antigen, patients with average statistic |
| Biomarker | YES |
| Classification | E2 (physiological factor - biochemical index) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | We measured plasma levels of eight microvascular dysfunction markers in CHD-PAH, and tested for associations with survival. |
| p Value | 0.0015 |
| Conclusion | Of the biomarkers studied, plasma vWF:Ag was independently associated with survival. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 610 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | VSD/ASD/AVSD/PDA/AVSD/VSD, PDA/DORV/TGA, VSD/SV |
| Reference | |
|---|---|
| PMID | 22068906 |
| Year | 2011 |
| Title | Plasma von Willebrand factor as a predictor of survival in pulmonary arterial hypertension associated with congenital heart disease |
| Sample | ||
|---|---|---|
| Population | adults | |
| Source | patients' data | |
| Region | Sao Paulo, Brasil | |
| Method | Mann-Whitney test | |
| Race | Brazilian | |
| Disease History | N/A | |
| Treatment History | N/A | |
| Group | PAH patients with CHD(average)(Treatment) | controls(Control) |
| Number | 46 | 30 |
| Age | 33.5 (15.0-60.2) years | N/A |
| Gender (Male: Female) | 17:29:00.000 | N/A |
| Marker Level | Median: 125 U/dL | Median: 109 U/dL |
